A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.
Also called NCT05110846
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 103 participants
- Sponsor
- Registry
-
NCT05110846
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Mexico
- Registry status
- Completed
Technical summary
Registry record NCT05110846. Randomized; quadruple masking; primary purpose treatment. Start 2022-02-22 (actual); primary completion 2023-02-28 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus
- Condition
- Obesity
- Condition
- Overweight
- Condition
- Type 2 Diabetes Mellitus
- Intervention (Drug)
- Placebo
- Intervention (Drug)
- CT-868
- Lead sponsor
- Carmot Therapeutics, Inc.
- Collaborator
- Hoffmann-La Roche
Record details
- Record id
cardio:ct-nct05110846- Content hash
f84d9692d77ce802bff6a2597324d377b35b30feb9238e1f9d717e233c44ecf7